Brief: Moberg Pharma Enters Financing Agreement For Further Investments In MOB-015

Moberg Pharma AB (publ)

23/03/2020 20:06

March 23 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * MOBERG PHARMA ENTERS FINANCING AGREEMENT OF UP TO SEK 216
MILLION FOR FURTHER INVESTMENTS IN MOB-015
    * MOBERG PHARMA AB (PUBL) - ENTERED INTO A CONVERTIBLE NOTE
AGREEMENT WITH NICE & GREEN S.A.
    * MOBERG PHARMA AB (PUBL) - AGREEMENT ENABLES CO TO PURSUE
MOB-015
POTENTIAL IN ONYCHOMYCOSIS AND CONDUCT AN ADDITIONAL CLINICAL
STUDY
    * MOBERG PHARMA AB (PUBL) - N&G AGREEMENT HAS TRANCHES OF
INITIALLY SEK 3 MILLION PER MONTH FOR FIRST SIX MONTHS
    * MOBERG PHARMA AB (PUBL) - HAS COMMITTED TO DRAW FIRST TWO
TRANCHES AND CAN THEN DECIDE IF AND WHEN REMAINING TRANCHES WILL
BE DRAWN.
    * MOBERG PHARMA AB (PUBL) - AGREEMENT WITH N&G ALSO CONTAINS
A
PROFIT SHARING PROGRAM, CONSISTING OF CASH COMPENSATION TO
MOBERG

Source text for Eikon:  ID:nWkr27rgtR 
Further company coverage:  MBPH.ST 

 ((Reuters.Briefs@thomsonreuters.com;))